Further functional validation will confirm whether there is a link between IGF‐1R recruitment and gene expression at the transcriptional and/or epigenetic level and shed further light on the association of nuclear IGF‐1R with more advanced PCa stage and its potential as a biomarker for IGF‐targeting cancer therapy. The gene discussed is IGF1; the disease is posterior cortical atrophy.